Literature DB >> 6161879

Use of the ELISA to screen for anti-thymocyte and anti-beta 2-microglobulin antibodies in leprosy and SLE.

G M Bahr, G A Rook, E Moreno, P M Lydyard, F Z Modabber, J L Stanford.   

Abstract

A report is given of the use of the enzyme-linked immunosorbent assay to measure antibody to preparations of human thymocyte membranes (HTMA) and to beta 2-microglobulin. The assay described is simple and rapid, and requires only small quantities of an easily stored membrane preparation. The advantages of this technique over conventional methods involving cytotoxicity are discussed. Raised levels of IgM antibody to beta 2-microglobulin were detected in sera from SLE patients. Raised levels of IgG and IgM antibody to HTMA were found in sera from most active lepromatous cases. Two of eight sera from SLE patients showed raised IgG anti-HMTA, but not raised IgM. An attempt was made to study the subclass of the IgG antibodies found, but when checked against purified human IgG myeloma proteins, the available anti-subclass sera were found to lack the necessary degree of specificity in this assay.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6161879      PMCID: PMC1458311     

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  24 in total

1.  Subpopulations of human lymphocytes defined by 2 -microglobulin.

Authors:  M W Fanger; G M Bernier
Journal:  J Immunol       Date:  1973-08       Impact factor: 5.422

Review 2.  Preparation and properties of lymphocyte plasma membrane.

Authors:  M J Crumpton; D Snary
Journal:  Contemp Top Mol Immunol       Date:  1974

3.  Clinical and serological profiles in leprosy.

Authors:  L J Matthews; J R Trautman
Journal:  Lancet       Date:  1965-11-06       Impact factor: 79.321

4.  Cytotoxins in disease. V. Various diseases.

Authors:  M Kreisler; S Naito; P I Terasaki
Journal:  Transplant Proc       Date:  1971-03       Impact factor: 1.066

5.  Serotyping for homotransplantation. 18. Refinement of microdroplet lymphocyte cytotoxicity test.

Authors:  K K Mittal; M R Mickey; D P Singal; P I Terasaki
Journal:  Transplantation       Date:  1968-11       Impact factor: 4.939

6.  Antilymphocyte antibodies in systemic lupus erythematosus. Effect on lymphocyte surface characteristics.

Authors:  R P Messner; M S Kennedy; J G Jelinek
Journal:  Arthritis Rheum       Date:  1975 May-Jun

7.  Antibodies against cell membrane constituents in systemic lupus erythematosus and related diseases. I. Cytotoxic effect of serum from patients with systemic lupus erythematosus (SLE) for allogeneic and for autologous lymphocytes.

Authors:  P Stastny; M Ziff
Journal:  Clin Exp Immunol       Date:  1971-04       Impact factor: 4.330

8.  Nature of cold-reactive antibodies to lymphocyte surface determinants in systemic lupus erythematosus.

Authors:  J B Winfield; R J Winchester; P Wernet; S M Fu; H G Kunkel
Journal:  Arthritis Rheum       Date:  1975 Jan-Feb

9.  Immunological aspects of leprosy with special reference to autoimmune diseases.

Authors:  O Wager
Journal:  Bull World Health Organ       Date:  1969       Impact factor: 9.408

10.  Antibodies to a specific surface antigen of T cells in human sera inhibiting mixed leukocyte culture reactions.

Authors:  P Wernet; H G Kunkel
Journal:  J Exp Med       Date:  1973-10-01       Impact factor: 14.307

View more
  12 in total

1.  Insulin binding substances, autoimmunity and type I diabetes in Kuwaiti patients and their kindred.

Authors:  E R Richens; A Shaltout; G M Bahr; N Abdella; A K Jayyab; M Al-Saffar; K Behbehani
Journal:  Acta Diabetol Lat       Date:  1989 Apr-Jun

2.  Antibody levels to mycobacteria in relation to HLA type: evidence for non-HLA-linked high levels of antibody to the 65 kD heat shock protein of M. bovis in rheumatoid arthritis.

Authors:  G M Bahr; G A Rook; M al-Saffar; J Van Embden; J L Stanford; K Behbehani
Journal:  Clin Exp Immunol       Date:  1988-11       Impact factor: 4.330

3.  Comparison between autoantibodies in malaria and leprosy with lupus.

Authors:  E Bonfa; R Llovet; M Scheinberg; J M de Souza; K B Elkon
Journal:  Clin Exp Immunol       Date:  1987-12       Impact factor: 4.330

4.  Marked enhancement in vivo of adjuvant activity of muramyl dipeptide to protein antigens and to synthetic weak immunogens with monoclonal anti-muramyl dipeptide antibodies.

Authors:  G M Bahr; D S Tello; L A Chedid
Journal:  Infect Immun       Date:  1985-08       Impact factor: 3.441

5.  HLA-DR-associated isotype-specific regulation of antibody levels to mycobacteria in rheumatoid arthritis.

Authors:  G M Bahr; G A Rook; A Shahin; J L Stanford; M I Sattar; K Behbehani
Journal:  Clin Exp Immunol       Date:  1988-04       Impact factor: 4.330

6.  Characterization of a factor in leprosy serum that inhibits the growth of mitogen-stimulated normal human lymphocytes.

Authors:  M A Kerr; Y M Hussein; R C Potts; J S Beck; M M Sheriff
Journal:  Immunology       Date:  1987-06       Impact factor: 7.397

7.  Characterization of polyclonal autoantibodies specific for beta 2-microglobulin in multiple myeloma sera.

Authors:  C Vincent; J P Revillard; R Bataille
Journal:  Clin Exp Immunol       Date:  1983-12       Impact factor: 4.330

8.  Antibodies to Mycobacterium paratuberculosis and nine species of environmental mycobacteria in Crohn's disease and control subjects.

Authors:  K J Stainsby; J R Lowes; R N Allan; J P Ibbotson
Journal:  Gut       Date:  1993-03       Impact factor: 23.059

9.  Antibody levels and in vitro lymphoproliferative responses to Streptococcus pyogenes erythrogenic toxin A and mitogen of patients with rheumatic fever.

Authors:  G M Bahr; A M Yousof; K Behbehani; H A Majeed; S Sakkalah; K Souan; I Jarrad; C Geoffroy; J E Alouf
Journal:  J Clin Microbiol       Date:  1991-09       Impact factor: 5.948

10.  Enzyme immunoassay of serum beta-2-microglobulin levels in various histological forms of leprosy with special reference to its elevation in type I and type II lepra reactions.

Authors:  K Saha; A Bhatnagar; V K Sharma; A K Chakrabarty
Journal:  J Clin Microbiol       Date:  1985-04       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.